Why DaVita Inc.’s (DVA) Stock Is Down 17.93%
As of Wednesday, August 05, DaVita Inc.’s DVA share price has dipped by 17.93%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Commentary & Analysis
Why DaVita Inc.’s (DVA) Stock Is Down 19.29%
As of Wednesday, August 05, DaVita Inc.’s DVA share price has dipped by 19.29%, which has investors questioning if this is right time to buy.Michael Rose
What You Need to Know About DaVita Inc.'s Q3 Earnings
DaVita Inc.'s fiscal Q3 earnings report was released on Tuesday, August 04. Let's dive in to see if (DVA) missed or beat analyst's expectations.Tudor Pop
3 Undervalued Health Care Providers & Services Stocks for Thursday, July 30
Discover the top 3 undervalued Health Care Providers & Services stocks for Thursday, July 30 based on AAII’s Stock Grades.Tudor Pop
Is DaVita Inc. (DVA) Overvalued?
We dive into why DaVita Inc. (DVA) could be considered overvalued on 2026-07-21, based on AAII’s Value Score and Grade.Tudor Pop
Financial Summary
| Share Statistics | DVA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11,175.4 | $1,982.5 | 79% |
|
| Shares Out (Mil) | 66.1 | 77.7 | 54% |
|
| Institutional Ownership | 96.5% | 86.1% | 70% |
|
| Float (Mil) | 33.9 | 52.1 | 39% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 739 | 637 | 64% |
|
| Price Change (52-week) |
28.2% | 79.7% | 68% |
|
| Growth | DVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.4% | 10.9% | 29% |
|
| Net Income (5yr) | (0.7%) | (1.6%) | 39% |
|
| EPS (5yr) | 9.3% | 0.3% | 45 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 22.6% | (17.9%) | 82% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 8 | |
| Current EPS | $3.578 | $14.845 | $17.015 | |
| Month Ago EPS | $3.922 | $14.879 | $17.222 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $3.934 | $14.846 | $17.182 | |
| Year/Year Chg | (11.0%) | 56.1% | 110.1% | |
| Financials | DVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14,010 | $1,504 | 87% |
|
| Net Income (TTM) (Mil) | $848 | $28 | 84% |
|
| EPS (TTM) | $12.382 | $0.200 | 96% |
|
| Operating Cash Flow (TTM) (Mil) | $2,193 | $162 | 89% |
|
| Net Cash Flow (TTM) (Mil) | ($45) | $9 | 20% |
|
| Long-Term Debt (Q1) (Mil) | $12,850 | $338 | 93% |
|
| Enterprise Value (Q1) (Mil) | na | $2,416 | na |
|
| Valuation | DVA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.79 | na |
|
| P/E | 14.9 | 25.8 | 37% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.8 | 1.2 | 65% |
|
| Ratios | DVA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.4% | 27.8% | 39% |
|
| Net Margin | 6.0% | 1.2% | 51% |
|
| ROA | 4.8% | 2.2% | 71% |
|
| ROE | (149.4%) | 7.2% | 6% |
|
| Liabilities to Assets | 93.9% | 58.6% | 91% |
|
| F-Score | 6 | 5 | 67% |
|
DaVita Inc. did not pass any screens on 8/20/2026.
